Search Results - Morris, Karla, R.N

  • Showing 1 - 1 results of 1
Refine Results
  1. 1
    A phase II study of lapatinib, a dual EGFR and HER-2 tyrosine kinase inhibitor, in patients with castration-resistant prostate cancer

    A phase II study of lapatinib, a dual EGFR and HER-2 tyrosine kinase inhibitor, in patients with castration-resistant prostate cancer by Whang, Young E., M.D., Ph.D, Armstrong, Andrew J., M.D, Rathmell, W. Kimryn, M.D., Ph.D, Godley, Paul A., M.D., Ph.D, Kim, William Y., M.D, Pruthi, Raj S., M.D, Wallen, Eric M., M.D, Crane, Jeffrey M., M.D, Moore, Dominic T., M.P.H, Grigson, Gayle, R.N, Morris, Karla, R.N, Watkins, Catharine P., B.A, George, Daniel J., M.D

    Published in Urologic oncology
    Get full text
    Items that this one cites
    Items that cite this one
    Article
    Save to List
    Saved in:

Search Tools: